CommercialCoverageMedium impact
Biomarker Testing in Risk Assessment and Management of Cardiovascular Disease
Blue Cross & Blue Shield of Mississippi·MS · Cardiology, Internal Medicine, Family Medicine +1 more·Medical Policy
We identified it
Jun 20, 2026
Summary
BCBS Mississippi updated their medical policy on biomarker testing for cardiovascular disease risk assessment, covering various cardiac biomarkers including apolipoprotein B, B-type natriuretic peptide, and lipoprotein testing. The policy defines coverage criteria for individual biomarkers and cardiovascular risk panels used as alternatives or additions to standard lipid panels.
Action Required
Review the updated biomarker testing policy to understand current coverage criteria for cardiovascular risk assessment tests. Billing team should verify coverage requirements for apolipoprotein testing, BNP, cystatin C, fibrinogen, and cardiovascular risk panels before submitting claims. Ensure proper documentation supports medical necessity for these tests when ordered as alternatives to standard lipid panels.